Article Details

PsyBio Therapeutics Retains KCSA Strategic Communications for Investor Relations Services

Retrieved on: 2021-04-09 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

PsyBio Therapeutics Retains KCSA Strategic Communications for Investor Relations Services. View article details on hiswai:

Excerpt

(TSXV: PSYB) ("PsyBio" or the "Company"), a biotechnology company pioneering the next generation of targeted psychoactive medications, announces ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up